Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Revenue (2021 - 2025)

HeartSciences' Revenue history spans 5 years, with the latest figure at $2419.0 for Q4 2025.

  • For Q4 2025, Revenue rose 102.06% year-over-year to $2419.0; the TTM value through Jan 2026 reached $8669.0, up 106.19%, while the annual FY2025 figure was $4350.0, 76.61% down from the prior year.
  • Revenue reached $2419.0 in Q4 2025 per HSCS's latest filing, up from $1900.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $14700.0 in Q1 2024 to a low of -$117598.0 in Q4 2024.
  • Average Revenue over 5 years is -$9968.6, with a median of $2740.0 recorded in 2022.
  • The largest YoY upside for Revenue was 653.85% in 2024 against a maximum downside of 3115.33% in 2024.
  • A 5-year view of Revenue shows it stood at $7484.0 in 2021, then plummeted by 57.24% to $3200.0 in 2022, then increased by 21.88% to $3900.0 in 2023, then tumbled by 3115.33% to -$117598.0 in 2024, then soared by 102.06% to $2419.0 in 2025.
  • Per Business Quant, the three most recent readings for HSCS's Revenue are $2419.0 (Q4 2025), $1900.0 (Q3 2025), and $4350.0 (Q2 2025).